Praxis Precision Medicines to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass., July 06, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal imbalance, today announced that management will participate in the following upcoming virtual investor conferences:

See the article here:
Praxis Precision Medicines to Present at Upcoming Investor Conferences

Related Post